Filings & corporate actions
46 results filed
CSVNext results · Q2 FY27
Expected 23 Oct 2026 – 8 Nov 2026
Estimate: filed 23–39 days after quarter end, last 5 times
Dividend
₹5.00 per share · last 30 Jul 2026
2026
- 30 JuldividendDividend · ₹5.00 per share-0.2%
- 24 JulresultsResults · Q1 FY27 · consolidated and standalone+3.9%NSE
- 21 JulshareholdingShareholding · 30 Jun 2026+0.4%NSE
- 25 JundividendDividend · ₹4.00 per share+1.8%
- 30 AprresultsResults · Q4 FY26 · consolidated and standalone+15.1%NSE
- 20 AprshareholdingShareholding · 31 Mar 2026+1.2%NSE
- 5 FebdividendDividend · ₹3.50 per share+0.3%
- 30 JanresultsResults · Q3 FY26 · consolidated and standalone+1.4%NSE
- 20 JanshareholdingShareholding · 31 Dec 2025-0.4%NSE
Reaction to results · all yearsrose on day 0 in 23 of 43 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q1 FY27 | 24 Jul 2026 | +3.9% | +8.0% | +7.1% | 5.7× |
| Q4 FY26 | 30 Apr 2026 | +15.1% | +20.9% | +14.2% | 25.5× |
| Q3 FY26 | 30 Jan 2026 | +1.4% | +2.4% | -0.7% | 0.4× |
| Q2 FY26 | 31 Oct 2025 | +3.8% | -2.3% | -2.9% | 2.7× |
| Q1 FY26 | 31 Jul 2025 | +0.8% | +1.3% | +2.5% | 1.3× |
| Q4 FY25 | 25 Apr 2025 | -3.4% | -3.6% | -2.1% | 1.7× |
| Q3 FY25 | 30 Jan 2025 | -0.9% | -2.5% | -19.7% | 0.8× |
| Q2 FY25 | 23 Oct 2024 | -6.3% | -4.4% | -5.1% | 6.0× |
| Q1 FY25 | 7 Aug 2024 | -2.7% | +0.8% | +3.2% | 2.8× |
| Q4 FY24 | 10 May 2024 | +6.2% | +8.0% | +18.6% | 6.9× |
| Q3 FY24 | 1 Feb 2024 | -1.9% | -1.9% | -6.9% | 1.9× |
| Q2 FY24 | 2 Nov 2023 | +5.3% | +8.7% | +9.3% | 7.3× |
| Q1 FY24 | 27 Jul 2023 | -5.1% | -5.3% | -11.9% | 2.7× |
| Q4 FY23 | 11 May 2023 | +7.1% | +1.8% | +2.6% | 4.1× |
| Q3 FY23 | 2 Feb 2023 | -6.7% | -2.7% | -3.1% | 3.1× |
| Q2 FY23 | 8 Nov 2022 | -8.4% | -6.1% | -6.1% | 4.2× |
| Q1 FY23 | 28 Jul 2022 | +7.4% | +13.2% | +19.7% | 3.1× |
| Q4 FY22 | 17 May 2022 | -6.1% | -16.0% | -6.9% | 6.5× |
| Q3 FY22 | 10 Feb 2022 | -3.1% | -6.8% | -10.2% | 0.9× |
| Q2 FY22 | 26 Oct 2021 | -1.2% | +1.7% | +2.8% | 2.0× |
| Q1 FY22 | 30 Jul 2021 | +4.6% | +9.4% | +13.9% | 2.4× |
| Q4 FY21 | 21 May 2021 | -1.6% | +4.4% | +11.3% | 1.3× |
| Q3 FY21 | 29 Jan 2021 | +2.2% | +7.2% | +3.9% | 0.9× |
| Q2 FY21 | 6 Nov 2020 | -1.9% | -7.5% | -5.8% | 0.7× |
| Q1 FY21 | 31 Jul 2020 | -1.4% | -0.3% | -6.2% | 0.8× |
| Q4 FY20 | 18 May 2020 | -2.3% | -2.7% | -0.5% | 1.4× |
| Q3 FY20 | 3 Feb 2020 | -1.9% | -5.6% | -1.6% | 2.7× |
| Q2 FY20 | 8 Nov 2019 | +2.0% | +13.4% | +5.7% | 2.5× |
| Q1 FY20 | 13 Aug 2019 | +3.6% | +9.6% | +20.2% | 8.5× |
| Q4 FY19 | 17 May 2019 | +2.3% | -2.2% | +4.2% | 0.9× |
| Q3 FY19 | 13 Feb 2019 | -0.8% | +2.0% | +4.0% | 0.3× |
| Q2 FY19 | 23 Nov 2018 | +0.2% | +3.6% | +8.1% | 0.2× |
| Q4 FY18 | 4 Sept 2018 | -0.3% | -4.7% | -12.3% | 0.3× |
| Q1 FY19 | 24 Aug 2018 | +5.9% | +2.1% | -5.0% | 2.0× |
| Q3 FY18 | 1 Mar 2018 | -0.1% | -2.6% | -4.7% | 7.3× |
| Q2 FY18 | 16 Nov 2017 | +0.3% | -0.8% | -0.9% | 0.9× |
| Q1 FY18 | 21 Aug 2017 | +0.1% | -1.3% | -0.9% | 0.5× |
| Q4 FY17 | 27 May 2017 | +0.7% | +1.2% | -8.4% | 0.4× |
| Q3 FY17 | 3 Feb 2017 | +1.0% | -0.7% | -12.1% | 1.4× |
| Q2 FY17 | 9 Nov 2016 | +1.1% | -0.1% | -6.7% | 1.1× |
| Q1 FY17 | 6 Aug 2016 | -0.5% | -0.9% | +22.3% | 0.3× |
| Q4 FY16 | 28 May 2016 | +0.5% | +5.1% | -11.1% | 1.2× |
| Q3 FY16 | 13 Feb 2016 | +2.8% | +5.5% | +13.0% | 0.7× |
| Average | +0.5% | +1.1% | +0.8% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth · Q1 FY27
CSVRevenue YoY+19.1%
Profit YoY+27.2%
Interest cost YoY+16.2%
Revenue QoQ+13.5%
Profit QoQ+29.0%
| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | +12.4% | +12.0% | — | +8.5% | +14.8% | +12.8% |
| Profit | +18.9% | +27.0% | — | +6.3% | +18.5% | +14.6% |
Key data
CSVOpen1,993.20
Day range1,945.90 – 2,018.70
52-week range1,272.60 – 2,038.60
From 52w high-3.6%
RSI (14)57.0
ATR (14)64.04
Volume2.46L
Avg volume (20D)3.62L
Rel volume0.68×
Volatility (1Y)28.3%
Turnover₹48.3Cr
SMA 50 / 2001,917.17 / 1,598.86
Delivery percentage
Latest · 6 Oct 202652.8%
20-day avg52.3%
1-year avg56.2%
Percentile (own history)70th
Range6.3–91.6%
Sessions1,731
Over the last 20 sessions LALPATHLAB settled 52.3% of its traded quantity, which is above average for an NSE equity. Its one-year average is 56.2%, so recent sessions are running 4.0 points lower than usual. The latest session ranks higher than 70% of the 1,731 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
IndustryHealthcare Service Provider
Performance returns
CSV| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | -0.36% | +1.14% | +2.03% | +16.86% | +47.83% | +22.97% |
Valuation
CSVMarket cap₹32,969 Cr
P/E (TTM)60.3
EPS (TTM)32.55
Shares outstanding16.76Cr
Listed23 Dec 2015
Ownership
CSVPromoter53.19%
Promoter Δ QoQ-0.02 pp
Public46.43%
FII17.36%
DII21.59%
Pledged0.00%
Quarterly results · consolidated
CSV| Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|
| Revenue (₹ Cr) | 730.6 | 659.8 | 702.7 | 797.7 |
| YoY chg | +10.7% | +10.6% | +16.6% | +19.1% |
| Net profit (₹ Cr) | 152.2 | 91.4 | 132.2 | 170.5 |
| YoY chg | +16.4% | -6.8% | -15.0% | +27.2% |
| Net margin | 20.8% | 13.9% | 18.8% | 21.4% |
| EPS | 9.01 | 5.41 | 7.85 | 10.13 |
Shareholding over time
CSVBy quarter
30 Jun 2026 · promoter 53.19% · public 46.43%2021-092026-06
- Promoter
- Public and others
- Promoter
- 53.19%
- Public
- 46.43%
- Promoter change
- -0.02 pp
- Filed
- 21 Jul 2026
- FII
- 17.36%
- DII
- 21.59%
- Promoter pledged
- 0.00%
Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.
Financials · quarterly statement
CSV₹ crore, as filed
| Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26A | Q1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 601.3 | 538.9 | 545.4 | 601.9 | 660.2 | 596.7 | 602.6 | 669.8 | 730.6 | 659.8 | 702.7 | 797.7 | |
| Other income | 18.1 | 18.3 | 18.4 | 20.6 | 21.9 | 25.1 | 25.8 | 28.1 | 24.8 | 24.4 | 24.0 | 31.9 | |
| Total income | 619.4 | 557.2 | 563.8 | 622.5 | 682.1 | 621.8 | 628.4 | 697.9 | 755.4 | 684.2 | 726.7 | 829.6 | |
| Total expenses | 467.2 | 441.3 | 443.9 | 472.6 | 499.0 | 483.5 | 475.0 | 516.8 | 551.8 | 529.8 | 566.6 | 600.9 | |
| └ Finance costs | 7.8 | 7.0 | 6.6 | 6.0 | 6.0 | 5.3 | 5.0 | 4.7 | 4.8 | 7.2 | 6.1 | 6.3 | |
| └ Depreciation | 35.9 | 36.0 | 36.6 | 34.7 | 35.3 | 35.5 | 36.4 | 34.6 | 40.5 | 42.1 | 44.6 | 44.4 | |
| Profit before tax | 152.2 | 115.9 | 119.9 | 149.9 | 183.1 | 138.3 | 153.4 | 181.1 | 203.6 | 124.3 | 160.1 | 228.7 | |
| Tax expense | 41.5 | 33.7 | 34.1 | 42.1 | 52.3 | 40.2 | (2.1) | 47.1 | 51.4 | 32.9 | 27.9 | 58.2 | |
| Net profit | 110.7 | 82.2 | 85.8 | 107.8 | 130.8 | 98.1 | 155.5 | 134.0 | 152.2 | 91.4 | 132.2 | 170.5 | |
| EPS | 6.58 | 4.88 | 5.07 | 6.39 | 7.76 | 5.80 | 9.29 | 7.94 | 9.03 | 5.42 | 7.86 | 10.15 | |
| Net margin | 18.41% | 15.25% | 15.73% | 17.91% | 19.81% | 16.44% | 25.80% | 20.01% | 20.83% | 13.85% | 18.81% | 21.37% | |
| PBT margin | 25.31% | 21.51% | 21.98% | 24.90% | 27.73% | 23.18% | 25.46% | 27.04% | 27.87% | 18.84% | 22.78% | 28.67% | |
| Tax rate | 27.27% | 29.08% | 28.44% | 28.09% | 28.56% | 29.07% | -1.37% | 26.01% | 25.25% | 26.47% | 17.43% | 25.45% |
A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 24 Jul 2026.
LALPATHLAB at a glance
- LALPATHLAB closed at ₹1,964.2 on 6 Oct 2026, -0.36% on the day, +23.0% over one year, 3.6% below its 52-week high of ₹2,038.6.
- Delivery was 52.8% of traded quantity on 6 Oct 2026, the 70th percentile of its own 1,731 sessions with a reading (20-session average 52.3%, 1-year average 56.2%).
- Market capitalisation is ₹32,969 crore at a trailing P/E of 60.3 (trailing EPS ₹32.55).
- Q1 FY27 results (consolidated, filed 24 Jul 2026): revenue ₹798 crore (+19.1% year on year), net profit ₹171 crore (+27.2%); the price moved +3.9% on the first session after.
- Promoters held 53.19% at 30 Jun 2026, down 0.02 percentage points on the previous filing.
- Q2 FY27 results are expected between 23 Oct 2026 and 8 Nov 2026, going by past filing dates — an estimate, not an announcement.
About
CSVMacro sectorHealthcare
Basic industryHealthcare Service Provider
ISININE600L01024
SeriesEQ
Listed23 Dec 2015
History from23 Dec 2015
Sessions2,668
Turnover rank#397
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.
More in Healthcare Services
CSV- APOLLOHOSPApollo Hospitals Enterprise Limited7,914.50-0.88%
- MAXHEALTHMax Healthcare Institute Limited902.50-1.58%
- FORTISFortis Healthcare Limited764.00+0.03%
- YATHARTHYatharth Hospital & Trauma Care Services Limited1,058.80+5.56%
- ASTERDMAster DM Quality Care Limited684.70-0.98%
- MANIPALHOSManipal Health Enterprises Limited690.50+3.52%
- ARTEMISMEDArtemis Medicare Services Limited318.35-1.77%
- NEPHROPLUSNephrocare Health Services Limited634.55-0.49%
- GKSLGujarat Kidney And Super Speciality Limited193.62+1.72%
- KIMSKrishna Institute of Medical Sciences Limited693.40-1.71%
- NHNarayana Hrudayalaya Ltd.1,723.80+0.08%
- MEDANTAGlobal Health Limited1,300.80-2.39%
All Healthcare Services stocks on the NSEAll Healthcare stocks on the NSE